December 17, 2018 Idera’s reinvention takes a hit The company’s lead, tilsotolimod, is meant to turn cold tumours hot, but it was investors who became frosty last week in response to mid-stage clinical results.
July 11, 2018 Logic defeats Idercryst and Baker Brothers The much criticised takeover of Idera by Biocryst will not, after all, take place.
June 07, 2018 Asco 2018 event analyser – A year of reset expectations Deciphera Pharmaceuticals emerges as one of the Asco 2018 winner as Jounce Therapeutics falls on weak data.
June 05, 2018 Asco 2018 – Toll like receptors join the immuno-oncology combo parade As investigators scrabble to find new cancer combos toll like receptor agonists come back into fashion.
October 02, 2015 Upcoming events: Tesaro looks for a second win and Idera hopes for blood cancer success